FL-based Neocis Secures $20M in Funding. Supporters included NVentures, the venture capital division of NVIDIA, and Mirae Asset Capital/Mirae Asset Venture Investment, venture capital firms linked to the Mirae Asset Financial Group that make investments in growth-stage healthcare and technology companies.
Read also – KY-based CSI Secures a Strategic Investment
The funds will be utilised by the company to grow both its operations and its clientele. Under the leadership of CEO Alon Mozes, Neocis produces and distributes Yomi®, a robotic surgical system for dentistry that has been granted FDA (Food and Drug Administration) clearance.
Read also – PA-based MedRisk Acquired Medata
With 16 FDA 510(k) certifications in all, the Yomi platform helps physicians with all stages of implant placement by providing streamlined digital planning and haptic guidance of surgical instrumentation, enabling users to deliver precise and efficient care.
Over 40,000 implants have been inserted via robotic help to date. Based on statistics from Neocis, it is put with a dental implant almost every six minutes.
Read also – CA-based Rainbow Secures $12M in Seed Funding
About Neocis
Neocis is using cutting-edge robots to revolutionise dental implant surgery. Neocis, the creator of Yomi, the first and only robotic technology for oral surgery to receive FDA clearance, collaborates closely with top surgeons to better understand their needs and treatment obstacles.
Read also – NYC-based Acupuncture Company WTHN Secures $5m in Series A Round Funding
